BJL
GMED icon

Brighton Jones LLC’s Globus Medical GMED Stock Holding History

Brighton Jones LLC’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,908
Closed -$423K – 1446
2026
Q1 		$423K Buy
+4,908
New +$441K 0.01% 770

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CCMG
Clark Capital Management Group Philadelphia, Pennsylvania $18.3B AUM 36.97% 1-Year Est. Return

Brighton Jones LLC's GMED Position: Q2 2026 in Review

Brighton Jones LLC sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 4,908 shares — an estimated $423K sold.

Brighton Jones LLC first reported a position in GMED in Q1 2026 and held it in 1 quarter. The position peaked at $423K in Q1 2026. 359 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Brighton Jones LLC reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Brighton Jones LLC sold 4,908 Globus Medical shares in Q2 2026, an estimated $423K.
  • Brighton Jones LLC first reported a position in Globus Medical in Q1 2026 and held it in 1 quarter.
  • Brighton Jones LLC's Globus Medical position peaked at $423K in Q1 2026.
  • 359 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.